Your browser doesn't support javascript.
loading
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.
Bohm, Alexandra K; DePetro, Jessica; Binding, Carmen E; Gerber, Amanda; Chahley, Nicholas; Berger, N Dan; Ware, Mathaeus; Thomas, Kaitlin; Senapathi, U; Bukhari, Shazreh; Chen, Cindy; Chahley, Erin; Grisdale, Cameron; Lawn, Sam; Yu, Yaping; Wong, Raymond; Shen, Yaoqing; Omairi, Hiba; Mirzaei, Reza; Alshatti, Nourah; Pedersen, Haley; Yong, Wee; Weiss, Samuel; Chan, Jennifer; Cimino, P J; Kelly, John; Jones, Steve; Holland, Eric; Blough, Michael; Cairncross, Gregory.
Afiliação
  • Bohm AK; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • DePetro J; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Binding CE; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Gerber A; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Chahley N; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Berger ND; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Ware M; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Thomas K; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Senapathi U; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Bukhari S; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Chen C; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Chahley E; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Grisdale C; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Lawn S; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Yu Y; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Wong R; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Shen Y; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Omairi H; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Mirzaei R; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Alshatti N; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Pedersen H; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Yong W; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Weiss S; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Chan J; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Cimino PJ; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Kelly J; The Clark H Smith Brain Tumour Centre, Calgary, Alberta, Canada.
  • Jones S; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Holland E; Charbonneau Cancer Institute, Calgary, Alberta, Canada.
  • Blough M; the Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cairncross G; the Michael Smith Genome Sciences Centre and University of British Columbia, Vancouver, British Columbia, Canada.
Neuro Oncol ; 22(8): 1150-1161, 2020 08 17.
Article em En | MEDLINE | ID: mdl-32296841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Fator de Crescimento Derivado de Plaquetas / Proteína Supressora de Tumor p53 / Glioblastoma / Células-Tronco Neurais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Fator de Crescimento Derivado de Plaquetas / Proteína Supressora de Tumor p53 / Glioblastoma / Células-Tronco Neurais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article